About Ribosomal RNA-processing protein 8
Ribosomal RNA-processing protein 8 (RRP8) is a protein
from Homo sapiens identified by UniProt accession
O43159, 456 residues long.
MolForge cross-references it against 0 known binders and
24 disease associations.
Target properties
| Protein name | Ribosomal RNA-processing protein 8 |
| UniProt accession | O43159 |
| Gene | RRP8 |
| Organism | Homo sapiens |
| Length | 456 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (24)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.49
- autism spectrum disorder · score 0.33
- endometrial cancer · score 0.13
- hepatocellular carcinoma · score 0.08
- hyperinsulinism due to INSR deficiency · score 0.04
- Systemic lupus erythematosus · score 0.03
- papillary thyroid carcinoma · score 0.02
- cancer · score 0.02
- neoplasm · score 0.02
- rheumatic disease · score 0.01
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O43159-F1 | alphafold | PREDICTED | 72.13 | — |
Amino-acid sequence (456 residues)
MFEEPEWAEA APVAAGLGPV ISRPPPAASS QNKGSKRRQL LATLRALEAA SLSQHPPSLC ISDSEEEEEE RKKKCPKKAS FASASAEVGK KGKKKCQKQG PPCSDSEEEV ERKKKCHKQA LVGSDSAEDE KRKRKCQKHA PINSAQHLDN VDQTGPKAWK GSTTNDPPKQ SPGSTSPKPP HTLSRKQWRN RQKNKRRCKN KFQPPQVPDQ APAEAPTEKT EVSPVPRTDS HEARAGALRA RMAQRLDGAR FRYLNEQLYS GPSSAAQRLF QEDPEAFLLY HRGFQSQVKK WPLQPVDRIA RDLRQRPASL VVADFGCGDC RLASSIRNPV HCFDLASLDP RVTVCDMAQV PLEDESVDVA VFCLSLMGTN IRDFLEEANR VLKPGGLLKV AEVSSRFEDV RTFLRAVTKL GFKIVSKDLT NSHFFLFDFQ KTGPPLVGPK AQLSGLQLQP CLYKRR
Explore Ribosomal RNA-processing protein 8 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets